| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/02/1993 | CA2130117A1 Mycobacterium vaccae for treatment of long term autoimmune conditions |
| 09/02/1993 | CA2117480A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 09/01/1993 | EP0558416A1 New 17-(methylene)-lactone spiro condensed steroids, method and intermediates for their production, their use as medicines and pharmaceutical compositions containing them |
| 09/01/1993 | EP0558287A1 Tetrahydrothiophene derivatives |
| 09/01/1993 | EP0558258A1 N-isoxazole-naphthylsulfonamide derivatives and their use as endothelin antagonists |
| 09/01/1993 | EP0558156A2 Intermediates for 3-aminopiperidine derivates |
| 09/01/1993 | EP0557787A1 Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments |
| 09/01/1993 | EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR |
| 09/01/1993 | EP0557408A1 Imidazolidinone compounds |
| 08/31/1993 | US5240960 Antiinflammatory agents |
| 08/31/1993 | US5240941 Thioxo quinoline compounds, composition and method of use |
| 08/31/1993 | US5240929 Lipoxygenase inhibitors |
| 08/31/1993 | US5240921 Cyclic pyridine-2,4- and -2,5-dicarboxylic acid diamides, processes for their preparation and their use |
| 08/31/1993 | US5240847 Cloned gene |
| 08/29/1993 | CA2090548A1 Tetrahydrothiophene derivatives |
| 08/26/1993 | DE4204922A1 Ketotricyclo(5.2.1.0)decan-derivate Ketotricyclo (5.2.1.0) decane derivatives |
| 08/25/1993 | EP0557075A1 4H-naphtho 1,2-b pyran derivatives as antiproliferative agents |
| 08/25/1993 | EP0556880A2 Medical use for atypical beta-adrenoceptor agonists |
| 08/25/1993 | EP0556813A1 Amphoteric tricyclic compounds as antihistaminic and antiallergic agents |
| 08/25/1993 | EP0556405A1 Pseudopentapeptides with immunomodulating activity |
| 08/25/1993 | EP0556333A1 Avirulent microbes and uses therefor: salmonella typhi |
| 08/25/1993 | EP0556292A1 Hepatitis c virus asialoglycoproteins |
| 08/25/1993 | CA2089184A1 Sulfonamide endothelin antagonists |
| 08/24/1993 | US5238836 Genetic engineering; isolated DNA sequences |
| 08/24/1993 | US5238689 Use of ruthenium red as immunosuppressive agents |
| 08/24/1993 | CA1321589C2 Intermediates for preparing benzo ¬5,6| cycloheptapyridines |
| 08/24/1993 | CA1321585C N-indolylethyl-sulphonic acid amides, processes for their preparation and their use |
| 08/20/1993 | CA2089974A1 Pharmaceutical compounds |
| 08/19/1993 | WO1993016190A1 Bacterial macromolecule extract, method for preparing same and pharmaceutical composition containing said extract |
| 08/19/1993 | WO1993016189A1 Novel macrocyclic lactones and a productive strain thereof |
| 08/19/1993 | WO1993016184A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
| 08/19/1993 | WO1993016087A2 Amadori reaction compounds and products, process for their manufacture, and their use |
| 08/19/1993 | WO1993016081A1 Piperidinyl thiacyclic derivatives |
| 08/19/1993 | WO1993016068A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 08/19/1993 | WO1993016036A1 Novel amidine derivatives, their preparation and their use as mediaments with ltb-4 antagonistic effect |
| 08/19/1993 | WO1993016029A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | WO1993015760A1 Dual carrier immunogenic construct |
| 08/19/1993 | WO1993015750A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 08/19/1993 | WO1993015735A1 (non descriptive)-a method for delaying hiv individual aids by administration of substituted azaspirane compounds |
| 08/19/1993 | WO1993014070A3 Novel imidazole derivatives, their preparation and therapeutic applications |
| 08/19/1993 | CA2427890A1 New amidine derivatives, the preparation and use thereof |
| 08/19/1993 | CA2130106A1 Amadori reaction compounds and products, process for their manufacture, and their use |
| 08/19/1993 | CA2129973A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 08/19/1993 | CA2129830A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
| 08/19/1993 | CA2129445A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
| 08/19/1993 | CA2129351A1 Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
| 08/19/1993 | CA2128529A1 Novel macrocyclic lactones and a productive strain thereof |
| 08/19/1993 | CA2106854A1 Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same |
| 08/18/1993 | EP0556024A1 Novel amidinonaphthyl furancarboxylate derivatives and acid addition salts thereof |
| 08/18/1993 | EP0555880A2 The CD40CR receptor and ligands therefor |
| 08/18/1993 | EP0555413A1 Methods and compositions for suppressing allograft rejection in mammals |
| 08/18/1993 | EP0555397A1 Polypeptide with kd hmfg differentiation antigen binding specificity |
| 08/18/1993 | EP0555286A1 Cell growth inhibitors |
| 08/18/1993 | EP0339075B1 Acylated uridine and cytidine and uses thereof |
| 08/17/1993 | US5236948 Sulphonamide derivatives |
| 08/17/1993 | US5236706 Pharmaceutical preparation for the maturation of prothymocytes |
| 08/17/1993 | US5236705 Fibrinolysis |
| 08/17/1993 | CA1321391C Substituted pyridine-2,4-dicarboxylic acid derivatives, processes for their preparation, the use thereof and medicaments based on these compounds |
| 08/11/1993 | EP0555068A1 Oxime derivatives as 5-lipoxygenase inhibitors |
| 08/11/1993 | EP0555067A1 Hydroxylamine derivatives as 5-lipoxygenase inhibitors |
| 08/11/1993 | EP0554829A2 Pyrazole derivatives with antiinflammatory, analgesic and antithrombolic activity |
| 08/11/1993 | EP0554634A1 Stabilized pharmaceutical composition comprising non-glycosylated, reduced, recombinant human IL-2 and process to prepare it |
| 08/11/1993 | EP0434749B1 Pharmaceutical compositions for eliciting an immunostimulant effect |
| 08/11/1993 | CA2079267A1 Amidinonaphthyl furancarboxylate derivatives and acid addition salts thereof |
| 08/10/1993 | US5234956 Reducing increase in calcium ion concenration; administering nitroglycerin, nitroprusside or derivatives thereof; treating AIDS, Alzheimer's, CNS disorders, cardiovascular disorders |
| 08/10/1993 | US5234932 Bronchodilators, antiallergens, antiinflammatory agents |
| 08/10/1993 | US5234930 Pyrazolopyridine compounds which have useful pharmaceutical utility |
| 08/10/1993 | US5234912 Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
| 08/10/1993 | US5234911 Antiinflammatory agents |
| 08/10/1993 | CA2042053C Lipid a monosaccharide analogues |
| 08/10/1993 | CA1321196C Antiviral tricyclic benzocyclopyrimidine derivatives |
| 08/08/1993 | CA2088864A1 Oxime derivatives |
| 08/07/1993 | WO1993015754A1 Hepatic growth factor receptor |
| 08/07/1993 | CA2129423A1 Hepatic growth factor receptor |
| 08/06/1993 | CA2129526A1 Novel amidine derivatives, their preparation and their use as medicaments with ltb4 antagonistic effect |
| 08/06/1993 | CA2088835A1 Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same |
| 08/05/1993 | WO1993015211A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides |
| 08/05/1993 | WO1993015205A2 Synthetic haemophilus influenzae conjugate vaccine |
| 08/05/1993 | WO1993015202A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
| 08/05/1993 | WO1993015083A1 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/05/1993 | WO1993015080A1 Azabicyclo compounds as calcium channel antagonists |
| 08/05/1993 | WO1993015073A1 Azabricyclic compounds as calcium channel antagonists |
| 08/05/1993 | WO1993015066A1 Benzopyran and related ltb4 antagonists |
| 08/05/1993 | WO1993014776A1 Icam-related protein |
| 08/05/1993 | WO1993014769A1 Method for making universal donor cells |
| 08/05/1993 | WO1993014767A2 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections |
| 08/05/1993 | WO1993014760A2 Methods |
| 08/05/1993 | WO1993014754A1 Histamine derivatives and methods for their use as immunomodulators |
| 08/05/1993 | WO1993014752A1 M. fermentans infection treatment |
| 08/05/1993 | WO1993014634A1 Protective effects of mutated superantigens |
| 08/05/1993 | WO1993009234A3 Suppressor and progenitor cells |
| 08/05/1993 | WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 08/05/1993 | CA2128879A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
| 08/05/1993 | CA2128779A1 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/05/1993 | CA2128536A1 Azabicyclo compounds as calcium channel antagonists |
| 08/05/1993 | CA2128535A1 A method for delaying hiv induced aids by administration of substituted azaperane compounds |
| 08/05/1993 | CA2128516A1 Histamine derivatives and methods for their use as immunomodulators |
| 08/05/1993 | CA2128415A1 Protective effects of mutated superantigens |
| 08/05/1993 | CA2126692A1 Method for making universal donor cells |
| 08/05/1993 | CA2125979A1 New polypeptides with a stimulating activity for granulocytes colonies; process for preparing the same and pharmaceutical compositions containing them |